Academic CD19-Directed CAR-T Therapy Shows 86.7% ORR in Follicular Lymphoma
The data, from a study of 15 patients, were presented at EHA’s 2025 Congress.
ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP
In Episode 4 of ImmunoLogic, Caroline Diorio, MD, FRCPC, FAAP, discussed her research on adverse events associated with cell therapy.
Around the Helix: Cell and Gene Therapy Company Updates – June 11, 2025
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
ImmunoLogic, Episode 3: "Breaking the Brain’s Barrier: CAR T-Cells Take on Glioblastoma" With Marcela Maus, MD, PhD
In Episode 3 of ImmunoLogic, Marcela Maus, MD, PhD, discussed her research on CAR-T for treating glioblastoma.
Lowering Barriers to Access for Liso-Cel Based on New Data
Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado, discussed the implications of a large scale analysis of liso-cel recipients.
Data Roundup: May 2025 Features Updates from ASGCT, ASCO, and More
Catch up on any of the key data updates you may have missed last month, with coverage highlights from the CGTLive™ team.
